Real-World Outcomes in Fingolimod-Treated Patients with Multiple Sclerosis in the Czech Republic: Results from the 12-Month GOLEMS Study
Crossref DOI link: https://doi.org/10.1007/s40261-016-0471-2
Published Online: 2016-10-26
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tichá, Veronika
Kodým, Roman
Počíková, Zuzana
Kadlecová, Pavla
Funding for this research was provided by:
Novartis s.r.o
License valid from 2016-10-26